Vilazodone Hydrochloride Tablet, Film Coated
Product Images NDC 76282-546

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Vilazodone Hydrochloride (NDC 76282-546). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vilazodone_10mg (Vilazodone Hydrochloride Tablets 10 mg)

Label for Vilazodone Hydrochloride tablets 10 mg, film-coated oral tablets, 30 count. Label highlights dosage strength, storage instructions, and manufacturer information including Exelan Pharmaceuticals Inc. and InvaGen Pharmaceuticals, Inc. Includes a barcode and a warning to dispense medication guide to patients.*

FDA Label Image

Vilazodone_20mg (Vilazodone Hydrochloride Tablets 20 mg)

Label for Vilazodone Hydrochloride Tablets 20 mg by Exelan Pharmaceuticals Inc. The label states the NDC 76282-545-30 and indicates the product contains 30 tablets. Instructions include storage temperature and light protection. Manufacturer details list InvaGen Pharmaceuticals, Inc. and Exelan Pharmaceuticals, Inc.*

FDA Label Image

Vilazodone_structure (Vilazodone HCl Strctr)

Chemical structure of vilazodone hydrochloride, depicting the molecular arrangement including indole and piperazine moieties, hydrochloride, and hydrate components.*

FDA Label Image

Vilazodone_40mg (Vilazodone 40mg Label)

Label for Vilazodone Hydrochloride tablets 40 mg, film-coated oral tablets. The label indicates a bottle containing 30 tablets, manufactured by Exelan Pharmaceuticals Inc. It includes storage instructions, a dosage advisory to see accompanying prescribing information, and a barcode. The label is primarily white with purple and orange text.*

FDA Label Image

Vilazodone_fig1 (Vilazodone Hydrochloride Figure 1)

A forest plot-type chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of vilazodone hydrochloride influenced by ethanol, CYP3A4 inhibitors (ketoconazole), CYP3A4 inducers (carbamazepine), and proton pump inhibitors (pantoprazole). The x-axis represents change relative to reference from 0.5 to 2.0 fold.*

FDA Label Image

Vilazodone_fig2 (Vilazodone Hydrochloride Figure 2)

A forest plot illustrating fold changes and 90% confidence intervals for various CYP3A4, CYP1A2, CYP2D6, CYP2C9, CYP2C19, and P-gp substrates. The graph shows substrates like Nifedipine, Caffeine, Debrisoquine, Flurbiprofen, Mephenytoin, and Digoxin with change values relative to a reference line at 1.0 on the x-axis.*

FDA Label Image

Vilazodone_fig3 (Vilazodone Hydrochloride Figure 3)

A forest plot showing fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC. The plot compares changes in different population groups by age (>65 years), gender (females), varying degrees of renal impairment (mild, moderate, severe), and hepatic impairment (mild, moderate, severe) relative to a reference standard.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.